Preview

Tevax Case Summary

Good Essays
Open Document
Open Document
723 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Tevax Case Summary
After analyzing the different internal resources and capabilities at Teva, there are several resources which effectively give them a sustained competitive advantage, and distinctly set them apart from the competition. Going forward, it is critical for Teva to continue some business practices that have led them to be an industry leader in the pharmaceutical realm. One example of a resource that they have effectively exploited is their acquisition strategy. Their proactive approach to acquisitions has proven to be extremely prosperous in a number of ways.
Teva’s arguably most important acquisition was Ivax, which provided them with a great amount of value and competitive advantage. Ivax gave them a large global presence, which they had previously
…show more content…
Their dedication to low costs paired with an essentially unmatched scale advantage through supply chain management has proven to distinctly separate them from their competitors. The supply chain brought tremendous value to the organization in terms of cost reduction; it’s broad reach and unique manner of management clearly made it a rare resource that provided costly to imitate scale advantages. No other firms in the industry operate a supply chain with the depth that Teva does; they have sustained competitive advantage for supply chain …show more content…
Continual expansion of scope and scale, a dedication to low prices, as well as being “first-to-file” have also profoundly contributed to Teva’s competitive edge in the industry. Each acquisition was done effectively and strategically and resulted in a variety of different benefits for Teva. If they wish to maintain their dominant presence in the pharmaceutical industry, they should certainly adhere to the acquisition and supply chain strategies that have propelled them to the top. Careful maintenance should be done in areas where Teva has a sustained competitive advantage to ensure that they keep the edge that they worked so arduously to obtain. They should also be cautious to not become too large and acquire too many other firms as it could cause them to become too diverse, which can complicate some of their strategies; acquisitions may not always generate value or competitive

You May Also Find These Documents Helpful

  • Good Essays

    Treva's Case Summary

    • 501 Words
    • 3 Pages

    Treva responds to all calls and emails in a timely manner from management, her peers, and internal and external agencies. She has been successful when being on-call for CI I rotation and responding to emergency situations within the 24hr. timeframe. She has not had any complaints from customers. She accepts new assignments and overflow hotlines, from other groups with a positive attitude. She continues to develop positive working relationships with staff DHSS, and other internal, and outside agencies. She keeps her supervisor informed of the status of her cases in our monthly conferences, and she does discuss difficult, or problematic cases with her supervisor also if she is going to be out of the office. Treva continues to demonstrate that she is able to remain calm and…

    • 501 Words
    • 3 Pages
    Good Essays
  • Good Essays

    The purpose of this article is to figure out the most efficient way for Loblaw to open up new business in pharmaceutical industry. We believe that acquisition is the best.…

    • 821 Words
    • 4 Pages
    Good Essays
  • Good Essays

    CVS is a corporation. A corporation is one of the most known business structures. Corporations can merge or acquire other businesses as an attempt to raise capital by reaching different markets and expanding the company. On Dec. 16, 2015 CVS declared its acquisition of targets pharmacy for around one point nine billion dollars. This deal was made so a CVS pharmacy would take place of every target pharmacy. This is an excellent example of how the corporations use acquiring other companies to broaden the corporation. This deal had a vast impact on CVS. Conforming to Mr. Trevors article, “CVS Earnings: Strong Performance Driven by Acquisitions and Growth In Specialty Business”, Mr.Trevor states “The acquisition of Target’s more than 1,600 pharmacy departments and 80 medical clinics makes CVS’ network of pharmacies the largest among its competitors. (Trevor, 2016, para. 5)” CVS taking targets 1,600 pharmacy departments and 80 medical clinics differentiates this company from its competitors because it is the largest pharmacy company. In addition with merging and acquisitions corporations is known for its effective advantages which including the selling of shares, its limit in liability and marketing power.…

    • 448 Words
    • 2 Pages
    Good Essays
  • Best Essays

    The manufacturer like Merck-Medco, Lilly-PCS were concerned about losing access to their industries to PBM. PBMs are companies that administer drug benefit programs for employers and health insurance carriers. Their contracts are directly to managed care organizations, self-insured employers, insurance companies, Medicare, and almost all Federal and State government health benefits plans. To make the benefit plan more affordable PBM lowered their claims processing fees and also offered rebate retention. PBM also processed prescription drug claims, reviewed prescriptions, offered generic and branded medicines through mail services as well. Hence, due to PBM’s efficiency of delivering and processing the drug cut overall cost of health care benefits, the manufacturer industry got a big hit in their business. So, in the early 1990S, a large growth of managed care changed the health care industry that also had a heavy impact on…

    • 2738 Words
    • 11 Pages
    Best Essays
  • Satisfactory Essays

    In order to remain competitive, a company must offer superior quality goods or services at the lowest prices possible. Supply chain enables a company to reduce the cost while increasing the efficiency. However, there are risks that are associated with such benefits. These issues should be properly addressed when a company is trying to rely heavily on supply chain management in order to stay competitive within its industry.…

    • 466 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Bbva Bank Case

    • 558 Words
    • 3 Pages

    1. How did BBVA make the transition from a strategy of growth driven by merger and acquisition to an organic strategy driven by innovation? How successful have they been?…

    • 558 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Pfizer Analysis

    • 1396 Words
    • 6 Pages

    Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo, and markets such well-known medications as Celebrex and Viagra. However, the pharmaceutical industry as a whole has undergone changes in recent years with significant consolidation taking place and with increased scrutiny regarding the ways in which drugs are developed, tested and marketed. In addition, recent controversies have erupted regarding Merck's drug Vioxx, and Pfizer has been the target of unwanted publicity regarding its painkiller Celebrex. This research considers the strategic position of Pfizer, including its strengths and weaknesses as well as the opportunities and threats that it faces, its strategic priorities and the acquisition strategy that it might follow.…

    • 1396 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Vf Corp Case Summary

    • 164 Words
    • 1 Page

    VF Corp developed expertise and capabilities to reduce costs and improve processes in its internal manufacturing that resulted in efficient performance and speedy delivery of products to market in “days instead of weeks”. The efficiency of its supply chain with quick turnaround creates a competitive advantages by reducing inventory and increase sales volume resulting in increased revenues. The company also created value by outsourcing productions, consequently reducing fixed cost and achieving better economies of scale. Shifting to suppliers in geographic regions where tariffs and quotas are more comparatively advantageous; achieving a corporate margin between 10-15%. Global acquisitions of diversified and profitable companies, not only increased VF’ market shares and revenue growth up - to 30% by 2008.…

    • 164 Words
    • 1 Page
    Satisfactory Essays
  • Powerful Essays

    The paper will present potential alternatives Vanguard Health Systems (VHS) must consider to realize growth. It will also seek to identify the best value discipline, generic strategy, and grand strategy for the organization. Upon the investigation of the various alternatives, a recommendation of a strategy or a combination of strategies will be presented. A growing trend among many businesses is through mergers and acquisitions. No longer are the days when one business can to dominate totally an entire industry. The health care system is not exempt. External environment factors play a significant role on how this industry operates as with most large businesses. These include remote, industry and operating environments that help to influence the activities that an organization will take in an effort to remain competitive according to (Pearce & Robinson, 2011). Vanguard Health System continues to monitor and evaluate these causative factors the paper will assist in evaluating how the better determine alternatives for the company’s future growth.…

    • 1432 Words
    • 6 Pages
    Powerful Essays
  • Best Essays

    Marino, J. (2009). Big Pharma’s Mid-Market Influence. Mergers & Acquisitions Report, 22(18), 12. Retrieved from EBSCOhost.…

    • 1899 Words
    • 8 Pages
    Best Essays
  • Best Essays

    Pfizer Industry Review

    • 4325 Words
    • 18 Pages

    Since the 1950s, the global pharmaceutical industry has evolved from “…a collection of several hundred, small, barely profitable firms to as small group of large, highly profitable firms” (Younkin, 2008, para. 1). This evolution has resulted in an oligopoly market structure with a few large firms, and significant barriers to market entry. In the last 20 years, pharmaceutical consolidation has continued with both vertical and horizontal mergers that have further shrunk the market. Since 1995, Pfizer has merged with five pharmaceutical firms (Industry Brief, 2003) in an attempt to increase its research and development divisions and to offset declines in new product development; increases in generic competition; and the emergence of bio-pharmaceutical firms (BCC Research, 2004). Although pharmaceutical firms no longer view mega mergers as “…a cure-all for [their] innovation drought” (Simons, 2007, para. 1), this trend towards consolidation is expected to continue, with firms focusing “…on targeted acquisitions and alliances with smaller…more innovative drug makers and biotechs” (Simons, 2007, para. 10).…

    • 4325 Words
    • 18 Pages
    Best Essays
  • Satisfactory Essays

    Business

    • 330 Words
    • 2 Pages

    4. Does Pfizer need to change the structure of its organization? If so, what changes are…

    • 330 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Paper - Wyeth

    • 1877 Words
    • 8 Pages

    The pharmaceutical-biotechnology industry has become increasingly consolidated over the past 15 years; in 1985 the 10 largest firms accounted for about 20 percent of worldwide sales, whereas in 2002 the 10 largest firms accounted for 48 of sales. Much of this consolidation is the result of mergers. The value of M&A activity in this industry exceeded $500 billion during the 1988 to 2000 period. A…

    • 1877 Words
    • 8 Pages
    Powerful Essays
  • Satisfactory Essays

    TEVA

    • 590 Words
    • 2 Pages

    There were a few small pharmaceutical companies in the region, but none at the level that Teva had developed themselves to be. This created a low level of intensity in Israel, but a high level of competition for the rest of the world. The U.S. is one of Teva’s main clients/nations that it supports, but there are many pharmaceutical companies that do the same thing. I believe that the low level of competition throughout Israel and surrounding areas allowed them to focus on the U.S and other operations. The demand for drugs is extremely high. This created a very large market for Teva to work with. During the 1960s and 70s, Teva merged with a number of Israeli companies, becoming the largest producer in Israel and started to expand internationally in the 80s. The ability to take over the Israeli market is what I believe created such a…

    • 590 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    Moreover, the pharmaceutical sector has been characterized with a very high M&A activity – a fact that further contributes to the constant variation in the rankings and the dynamism of the pharmaceutical industry in general. For example, in 2003, before the merger took place, Aventis occupied fifth place, as measured by level of revenues, and Sanofi came in thirteenth. After the conclusion of the merger, Sanofi-Aventis emerged as the third largest company in the industry. Therefore, the huge competitive pressure has led to an increasing consolidation in the sector. In 1985, the ten largest…

    • 5913 Words
    • 19 Pages
    Powerful Essays